Responder Analysis For Fev1 Improvement With Dupilumab In Patients With Persistent Asthma And Elevated Eosinophil Levels

被引:0
|
作者
Castro, M. [1 ]
Teper, A. [2 ]
Wang, L. [2 ]
Pirozzi, G. [2 ]
Radin, A. [3 ]
Graham, N. [3 ]
Weinstein, S. [3 ]
Wenzel, S. E. [4 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Sanofi, Bridgewater, NJ USA
[3] Regeneron Pharmaceut, Tarrytown, NY USA
[4] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1321
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Forced Oscillation Technique Predicts FEV1 Improvement in Untreated COPD Patients
    Takahashi, S.
    Akamatsu, T.
    Tamura, K.
    Masuda, T.
    Tanaka, Y.
    Watanabe, H.
    Endo, Y.
    Suzuki, T.
    Noguchi, R.
    Saigusa, M.
    Yamamoto, A.
    Shishido, Y.
    Akita, T.
    Morita, S.
    Asada, K.
    Shirai, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] Increase in blood eosinophil count over time and sputum IL8 are associated with FEV1 decline in asthma
    Graff, S.
    Moermans, C.
    Gerday, S.
    Henket, M.
    Paulus, V
    Guissard, F.
    Louis, R.
    Schleich, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline
    Marc-Malovrh, Mateja
    Camlek, Luka
    Skrgat, Sabina
    Kern, Izidor
    Flezar, Matjaz
    Dezman, Manca
    Korosec, Peter
    RESPIRATORY MEDICINE, 2020, 162
  • [44] Dupilumab reduced rates of severe exacerbations and improved pre-bronchodilator FEV1 in patients with moderate to severe asthma regardless of exacerbation history: LIBERTY ASTHMA TRAVERSE
    Corren, J.
    Katelaris, C. H.
    Castro, M.
    Maspero, J. F.
    Humbert, M.
    Halpin, D. M.
    Altincatal, A.
    Pandit-Abid, N.
    Soler, X.
    Radwan, A.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    ALLERGOLOGIE, 2023, 46 (08) : 544 - 545
  • [45] Increase in Blood Eosinophil Count Over Time and Sputum IL8 are Associated with FEV1 Decline in Asthma
    Graff, S.
    Moermans, C.
    Gerday, S.
    Henket, M.
    Paulus, V.
    Guissard, F.
    Louis, R.
    Schleich, F.
    LUNG, 2025, 203 (01)
  • [46] Vitamin D Levels In Patients Of COPD And Its Relation With Fev1/FVC
    Chopra, V.
    Kaur, P.
    Jain, H.
    Bamrah, V.
    N, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [47] CAPTAIN STUDY: EFFECTS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ON FEV1 IMPROVEMENT IN ASTHMA ACCORDING TO AGE
    Hanania, N.
    Bailes, Z.
    Barnes, N.
    Gardiner, F.
    Lugogo, N.
    Mannino, D.
    Mehta, V.
    Nyanjom, D.
    Sitz, K.
    Kerstjens, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S28 - S28
  • [48] Assessing the impact of body mass index on FEV1% and quality of life in asthma patients
    Jain, Sarus
    Golmohamed, Amin
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [49] Exhaled Nitric Oxide Correlates with Post-bronchodilator Improvement of FEV1 in Chronic Childhood Asthma
    Baek, H. S.
    Kim, H. J.
    Kim, Y. D.
    Oh, J. W.
    Shin, J. H.
    Lee, H. B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB50 - AB50
  • [50] Residual Volume Reversibility Is a Better Test in Identifying Reversible Airway Disease Compared to FEV1 Reversibility in Patients With Chronic Persistent Asthma
    Sazgar, Sasan
    Rashidian, Ali
    Abejie, Belayneh
    Jain, Vipul
    Vempilly, Jose
    CHEST, 2016, 150 (04) : 919A - 919A